title: A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2-induced potentiation of P2X3 receptor currents in inflamed rats.
abstract: Sensitization of purinergic P2X receptors is one of the mechanisms responsible for exaggerated pain responses to inflammatory injuries. Prostaglandin E2 (PGE2), produced by inflamed tissues, is known to contribute to abnormal pain states. In a previous study, we showed that PGE2 increases fast inactivating ATP currents that are mediated by homomeric P2X3 receptors in dorsal root ganglion (DRG) neurons isolated from normal rats. Protein kinase A (PKA) is the signalling pathway used by PGE2. Little is known about the action of PGE2 on ATP currents after inflammation, although the information is crucial for understanding the mechanisms underlying inflammation-induced sensitization of P2X receptors. We therefore studied the effects of PGE2 on P2X3 receptor-mediated ATP currents in DRG neurons dissociated from complete Freund's adjuvant (CFA)-induced inflamed rats. We found that PGE2 produces a large increase in ATP currents. PKCepsilon, in addition to PKA, becomes involved in the modulatory action of PGE2. Thus, PGE2 signalling switches from a solely PKA-dependent pathway under normal conditions to both PKA- and PKC-dependent pathways after inflammation. Studying the mechanisms underlying the switch, we demonstrated that cAMP-responsive guanine nucleotide exchange factor 1 (Epac1) is up-regulated after inflammation. The Epac agonist CPT-OMe mimics the potentiating effect of PGE2 and occludes the PKC-mediated PGE2 action on ATP currents. These results suggest that Epac plays a critical role in P2X3 sensitization by activation of de novo PKC-dependent signalling of PGE2 after inflammation and would be a useful therapeutic target for pain therapies.
authors: Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555-1069, USA.
authors: Congying
authors: C
authors: Wang
authors: Yanping
authors: Y
authors: Gu
authors: Guang-Wen
authors: GW
authors: Li
authors: Li-Yen Mae
authors: LY
authors: Huang
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism*; D005727:Ganglia, Spinal / Q000378:metabolism; D020662:Guanine Nucleotide Exchange Factors / Q000378:metabolism*; D007249:Inflammation / Q000378:metabolism*; D009619:Nociceptors / Q000378:metabolism*; D051744:Protein Kinase C-epsilon / Q000378:metabolism*; D051381:Rats; D018048:Receptors, Purinergic P2 / Q000378:metabolism; D058477:Receptors, Purinergic P2X3; D015398:Signal Transduction / Q000502:physiology
chemical_list: C482601:Epac protein, mouse; D020662:Guanine Nucleotide Exchange Factors; C546409:P2rx3 protein, mouse; D018048:Receptors, Purinergic P2; D058477:Receptors, Purinergic P2X3; D000255:Adenosine Triphosphate; D017868:Cyclic AMP-Dependent Protein Kinases; D051744:Protein Kinase C-epsilon; D015232:Dinoprostone
references: Neuron. 1999 Sep;24(1):253-60
references: 10677042
references: J Physiol. 1997 Dec 1;505 ( Pt 2):503-11
references: 9423189
references: Eur J Pharmacol. 1997 Dec 11;340(2-3):227-41
references: 9537820
references: J Neurochem. 1998 Jun;70(6):2606-12
references: 9603227
references: J Neurosci. 1998 Aug 15;18(16):6081-92
references: 9698303
references: J Neurosci. 1998 Dec 15;18(24):10345-55
references: 9852572
references: Science. 1998 Dec 18;282(5397):2275-9
references: 9856955
references: Br J Pharmacol. 1999 Jan;126(1):326-32
references: 10051152
references: Eur J Pharmacol. 1999 Feb 12;367(1):33-9
references: 10082262
references: J Neurophysiol. 1999 Sep;82(3):1590-8
references: 10482772
references: Physiol Rev. 1999 Oct;79(4):1193-226
references: 10508233
references: Trends Pharmacol Sci. 2004 Sep;25(9):487-93
references: 15559251
references: Pain. 2005 Jan;113(1-2):185-90
references: 15621379
references: J Neurosci. 2005 Jan 5;25(1):208-14
references: 15634783
references: J Biochem. 2004 Dec;136(6):761-7
references: 15671486
references: J Neurosci. 2005 Jun 29;25(26):6119-26
references: 15987941
references: Biochem Soc Trans. 2005 Aug;33(Pt 4):635-8
references: 16042561
references: Br J Anaesth. 2000 Apr;84(4):476-88
references: 10823099
references: J Neurosci. 2000 Jun 15;20(12):4680-5
references: 10844037
references: J Neurosci. 2005 Aug 24;25(34):7734-42
references: 16120774
references: Mol Pain. 2005;1:26
references: 16159392
references: Pain. 2005 Dec 15;119(1-3):38-48
references: 16298067
references: Mol Pharmacol. 2006 Mar;69(3):846-56
references: 16306229
references: J Biol Chem. 2006 Apr 28;281(17):11805-14
references: 16484231
references: Biochim Biophys Acta. 2007 Feb;1773(2):166-75
references: 17052768
references: Mol Pain. 2007;3:22
references: 17692121
references: J Biol Chem. 2001 May 11;276(19):16083-91
references: 11278900
references: J Biol Chem. 2001 Jun 15;276(24):21077-82
references: 11264291
references: J Physiol. 2001 Jul 15;534(Pt. 2):437-45
references: 11454962
references: J Physiol. 2001 Nov 15;537(Pt 1):115-23
references: 11711566
references: Nat Cell Biol. 2001 Nov;3(11):1020-4
references: 11715024
references: J Neurosci. 2002 Jan 1;22(1):93-102
references: 11756492
references: Pain. 2002 Jan;95(1-2):41-7
references: 11790466
references: J Neurosci. 2000 Aug 1;20(15):RC90
references: 10899177
references: Pain. 2002 Apr;96(3):285-96
references: 11973001
references: Am J Physiol Regul Integr Comp Physiol. 2002 Jun;282(6):R1618-27
references: 12010743
references: J Neurosci. 2002 Sep 1;22(17):7444-52
references: 12196566
references: Physiol Rev. 2002 Oct;82(4):1013-67
references: 12270951
references: Nat Cell Biol. 2002 Nov;4(11):901-6
references: 12402047
references: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17179-84
references: 12482951
references: Neuroscience. 2003;120(1):219-26
references: 12849754
references: Neuron. 2003 Aug 14;39(4):613-24
references: 12925276
references: Nat Rev Mol Cell Biol. 2003 Sep;4(9):733-8
references: 14506476
references: Neuroscientist. 2003 Oct;9(5):370-8
references: 14580121
references: Nat Rev Neurosci. 2004 Feb;5(2):135-45
references: 14735116
references: J Neurosci. 2004 Jan 21;24(3):642-51
references: 14736850
references: J Physiol. 2004 Jan 15;554(Pt 2):301-8
references: 12832496
references: Biochem J. 2004 Aug 15;382(Pt 1):101-10
references: 15144237
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11868-73
references: 15292517
references: J Biol Chem. 2004 Sep 17;279(38):39485-94
references: 15262999
references: Endocrinology. 1996 Jun;137(6):2572-9
references: 8641211
references: Br J Pharmacol. 1995 Dec;116(7):2828-37
references: 8680713
references: J Neurosci. 1997 Jul 15;17(14):5297-304
references: 9204914
references: Brain Res. 1997 Oct 24;772(1-2):82-6
references: 9406958
references: J Biol Chem. 2000 Apr 7;275(14):10190-5
references: 10744703